Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
|Articles|February 2, 2020
- Pharmaceutical Technology-02-02-2020
- Volume 44
- Issue 2
Automated Neck Bander
The Pharmafill NB1, Series II from Deitz is an automated neck bander that can accommodate shrinkbands and full sleeve labels from .79–10 inches in length.
The Pharmafill NB1, Series II from Deitz is an automated neck bander that can accommodate shrinkbands and full sleeve labels from .79–10 inches in length, giving packaging professionals the ability to apply tamper-evident neck bands to a larger variety of glass and plastic bottles, jars, vials, dropper bottles, metal tins, and other containers in various sizes and shapes on the same neck banding machine.
The stainless-steel device operates at speeds up to 100 bottles per minute and comes equipped with a proprietary touch-screen HMI and a full-access interior for simplified rollstock replacement. The neck bander works with all heat-shrinkable banding materials from 25–123 mm in width applied over caps ranging from 14–76 mm in diameter. Vertical perforators, a photoelectric print registration, a companion heat tunnel, and a conveyor are also available with the device.
Articles in this issue
over 6 years ago
Pre-Clinical: Laying the Right Foundationover 6 years ago
Global Supply Issues Create Challengesover 6 years ago
The Call for a Rapid Responseover 6 years ago
ICH to Revise Quality Risk Management Guidelineover 6 years ago
Brexit: What Happens Next for Pharma?over 6 years ago
Of Serious Concern?over 6 years ago
Best Practices in Using Isolator Technologyover 6 years ago
Data Management Practicesover 6 years ago
Blister Packaging MachineRelated to this article
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.